At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 217 enrolled
Drug / intervention
SVT-15652 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase III, Multicenter, Randomized, Double-Blind Clinical Trial to Assess the Efficacy and Safety of SVT-15652 Otic Solution Compared to Placebo for the Treatment of Fungal Otitis Externa (Otomycosis)
In Brief
A Phase 3 clinical trial evaluating SVT-15652 and Placebo for Otomycosis. Completed, enrolled 217 participants across 1 site.
Detailed Summary
Multicenter, randomized, 2-arm parallel-group, double blind, placebo-controlled study in patients suffering from Otomycosis. This study will compare the efficacy and safety of SVT-15652 otic solution to that of Placebo, when administering one vial twice daily during 14 days.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOtomycosis
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
20192020202120222023202420252026
First PostedSep 2018
Enrollment StartFeb 2020
Primary CompletionOct 2021
TodayJul 2026
First PostedSep 26, 2018
Enrollment StartFeb 27, 2020
Primary CompletionOct 25, 2021
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 7.8 years ago
Interventions
SVT-15652drug
1 vial twice daily
Placebodrug
1 vial twice daily